Gender affirmative care of transgender people: a single center's experience in Korea
Autor: | Gyu Yeon Choi, Jeong Jae Lee, Yun Ha Jang, Hyun Hye Lim, Eun Sil Lee |
---|---|
Rok vydání: | 2019 |
Předmět: |
Gender dysphoria
medicine.medical_specialty Transgender people MEDLINE gender dysphoria Single Center lcsh:Gynecology and obstetrics 03 medical and health sciences 0302 clinical medicine Transgender Reproductive Endocrinology gender affirmative care Medicine lcsh:RG1-991 030219 obstetrics & reproductive medicine business.industry Medical record Obstetrics and Gynecology Testosterone (patch) medicine.disease Identified patient 030220 oncology & carcinogenesis Family medicine Original Article transgender persons business |
Zdroj: | Obstetrics & Gynecology Science, Vol 62, Iss 1, Pp 46-55 (2019) Obstetrics & Gynecology Science |
ISSN: | 2287-8580 2287-8572 |
DOI: | 10.5468/ogs.2019.62.1.46 |
Popis: | Objective To investigate the clinical characteristics and medical management of transgender people in South Korea. Methods The electronic medical records of 54 transgender persons who had visited Soonchunhyang University Hospital from January 2016 to December 2017 for medical care were retrospectively reviewed. We identified patient demographics and gender identity-related characteristics. Moreover, we compared our hospital protocol with official guidelines. Results At the time of the medical record search, the average age of these 52 transgender persons was 27 years, and 46 (88.5%) were Korean. Ten (19.2%) persons had a mental disorder other than gender dysphoria. Gonadotropin-releasing hormone agonist, estrogen, antiandrogen agents, and testosterone were used according to the guidelines issued by the World Professional Association for Transgender Health and the Endocrine Society. Ten (19.2%) transgender persons, including 6 (22.2%) male-to-females (MTFs) and 4 (16.0%) female-to-males (FTMs), had a mental disorder other than gender dysphoria. Among persons who were administered testosterone, 3 had high triglyceride and lipoprotein cholesterol levels. Nine patients, including 6 (66.7%) MTFs and 3 (33.3%) FTMs, underwent both gonadectomy and gender affirmative surgery. Seven (43.8%) persons, including 1 (14.3%) MTF and 6 (85.7%) FTMs, underwent only gonadectomy. There was a significant difference (P=0.040) between MTFs and FTMs. Conclusion Medical providers should have adequate knowledge of and experience in managing transgender persons and be familiar with the relevant guidelines and literature. Long-term follow-up examinations should also be performed. |
Databáze: | OpenAIRE |
Externí odkaz: |